Surgery Partners, Inc.
SGRY Healthcare Medical Care Facilities
Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS fell 500.0%, free cash flow fell 60.6% and total debt rose 4.92%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.
Follow SGRY
Surgery Partners, Inc. (SGRY) EV/Sales
As of 16 October 2026, Surgery Partners, Inc. (SGRY) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 1.5× (August 2019) to 3.5× (April 2022); the current reading is higher than 15% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.6× | (11.47%) |
| FY2024 | 1.9× | (22.42%) |
| FY2023 | 2.4× | 27.50% |
| FY2022 | 1.9× | (35.04%) |
| FY2021 | 2.9× | 35.68% |
| FY2020 | 2.1× | 20.00% |
| FY2019 | 1.8× | 20.12% |
| FY2018 | 1.5× | (25.63%) |
| FY2017 | 2.0× | 7.29% |
| FY2016 | 1.8× | (8.39%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.7× | 11.82% |
| Mar 2026 | 1.5× | (7.71%) |
| Dec 2025 | 1.6× | (11.76%) |
| Sep 2025 | 1.9× | (2.11%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| ARDT Ardent Health, Inc. compare | 0.3× |
| AMN AMN Healthcare Services Inc compare | 0.6× |
| ASTH Astrana Health, Inc. compare | 0.6× |
| MD Pediatrix Medical Group, Inc. compare | 1.2× |
| ADUS Addus HomeCare Corporation compare | 1.4× |
| SGRY Surgery Partners, Inc. | 1.6× |
| BKD Brookdale Senior Living Inc. compare | 2.1× |
| SNDA Sonida Senior Living, Inc. compare | 6.0× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)